We further evaluated the value of CEA, IL-1β, IL-6, and IL-8 for the auxiliary diagnosis and prognostic evaluation of lung cancer, to provide more accurate potential molecular biomarkers for the diagnosis of the patient with lung cancer. This evidence concerns the gene CEACAM5 and lung carcinoma.